Jeffrey Arvin Fink
Jeffrey Arvin Fink is on the board of Progenitor, Inc., Lipocine, Inc. and Navigen, Inc. and Managing Director at Gambel Oaks Advisors LLC.
Mr. Fink previously was Partner at Dresdner Kleinwort Securities LLC, Head-Mergers & Acquisitions at Prudential Vector Healthcare Group and Head-Healthcare Investment Banking at Robert W. Baird & Co., Inc.
Mr. Fink received an MBA from the University of Michigan and an undergraduate degree from Kalamazoo College.
Transactions
Date
Transaction
Value
| 12/16/2020 | 5,625 | Derivative/Non-derivative trans. at $0 per share. | 0 |
